X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4950) 4950
Publication (607) 607
Book Review (38) 38
Book Chapter (21) 21
Conference Proceeding (8) 8
Magazine Article (4) 4
Dissertation (3) 3
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
progression-free survival (3993) 3993
humans (3456) 3456
index medicus (3143) 3143
oncology (2688) 2688
female (2223) 2223
middle aged (1931) 1931
male (1899) 1899
aged (1702) 1702
adult (1437) 1437
chemotherapy (1345) 1345
cancer (1342) 1342
prognosis (1185) 1185
treatment outcome (1108) 1108
disease-free survival (1079) 1079
survival (1047) 1047
overall survival (858) 858
care and treatment (780) 780
antineoplastic combined chemotherapy protocols - therapeutic use (779) 779
retrospective studies (760) 760
aged, 80 and over (719) 719
hematology (693) 693
metastasis (648) 648
antineoplastic agents - therapeutic use (578) 578
therapy (568) 568
analysis (550) 550
patients (508) 508
tumors (504) 504
research (493) 493
neoplasm staging (482) 482
survival analysis (457) 457
survival rate (444) 444
surgery (436) 436
clinical trials (435) 435
disease progression (434) 434
kaplan-meier estimate (429) 429
medicine & public health (411) 411
progression-free (404) 404
development and progression (392) 392
young adult (386) 386
patient outcomes (376) 376
hematology, oncology and palliative medicine (368) 368
medical prognosis (353) 353
rituximab (348) 348
carcinoma (328) 328
radiotherapy (324) 324
follow-up studies (311) 311
drug therapy (305) 305
time factors (303) 303
risk factors (300) 300
bevacizumab (298) 298
progression free survival (297) 297
trial (293) 293
adolescent (291) 291
health aspects (286) 286
cancer therapies (285) 285
pharmacology & pharmacy (282) 282
open-label (281) 281
phase-ii trial (281) 281
breast cancer (280) 280
recurrence (276) 276
transplantation (271) 271
combined modality therapy (269) 269
neoplasm metastasis (268) 268
clinical neurology (266) 266
proportional hazards models (262) 262
abridged index medicus (261) 261
non-hodgkins-lymphoma (261) 261
biomarkers (258) 258
expression (248) 248
medical research (247) 247
phase-iii trial (246) 246
antineoplastic combined chemotherapy protocols - adverse effects (245) 245
article (245) 245
ovarian cancer (241) 241
phase-iii (237) 237
phase-ii (236) 236
metastases (232) 232
randomized controlled trials as topic (227) 227
diagnosis (225) 225
immunotherapy (223) 223
mutation (221) 221
multivariate analysis (215) 215
lymphomas (211) 211
lung cancer (210) 210
colorectal cancer (209) 209
efficacy (209) 209
cisplatin (206) 206
studies (202) 202
glioblastoma (200) 200
lung neoplasms - drug therapy (200) 200
prospective studies (200) 200
neoplasms. tumors. oncology. including cancer and carcinogens (197) 197
toxicity (196) 196
usage (196) 196
antineoplastic agents - administration & dosage (195) 195
radiology, nuclear medicine & medical imaging (192) 192
antineoplastic combined chemotherapy protocols - administration & dosage (187) 187
randomized-trial (187) 187
medicine, general & internal (183) 183
1st-line treatment (181) 181
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4761) 4761
Chinese (56) 56
German (41) 41
French (28) 28
Spanish (23) 23
Korean (18) 18
Russian (16) 16
Polish (9) 9
Hungarian (6) 6
Czech (5) 5
Japanese (5) 5
Turkish (3) 3
Portuguese (2) 2
Dutch (1) 1
Esperanto (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
JAMA Internal Medicine, ISSN 2168-6106, 08/2015, Volume 175, Issue 8, pp. 1389 - 1398
Journal Article
Statistics in Medicine, ISSN 0277-6715, 02/2019, Volume 38, Issue 5, pp. 703 - 719
This paper considers methods for estimating the association between progression‐free and overall survival in oncology trials. Copula‐based, nonparametric, and... 
overall survival | Kendall's τ | copula | progression‐free survival | inverse probability of censoring weights | multistate model | progression-free survival
Journal Article
Cancer, ISSN 0008-543X, 03/2011, Volume 117, Issue 6, pp. 1262 - 1271
BACKGROUND: The authors investigated the putative surrogate endpoints of best response, complete response (CR), confirmed response, and progression‐free... 
extensive stage small‐cell lung cancer | pooled analysis | tumor response | surrogate endpoints | progression‐free survival | extensive stage small-cell lung cancer | progression-free survival
Journal Article
Journal Article